IRIS
CIVES, MAURO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.962
EU - Europa 490
AS - Asia 266
SA - Sud America 4
OC - Oceania 3
AF - Africa 2
Totale 3.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.960
SE - Svezia 211
CN - Cina 202
IT - Italia 120
GB - Regno Unito 44
VN - Vietnam 23
FI - Finlandia 20
FR - Francia 20
BE - Belgio 18
DE - Germania 18
SG - Singapore 17
UA - Ucraina 16
IN - India 12
IE - Irlanda 10
BR - Brasile 4
HK - Hong Kong 3
NL - Olanda 3
AT - Austria 2
CA - Canada 2
HU - Ungheria 2
NZ - Nuova Zelanda 2
OM - Oman 2
RO - Romania 2
ZA - Sudafrica 2
AL - Albania 1
AM - Armenia 1
AU - Australia 1
BD - Bangladesh 1
EE - Estonia 1
HR - Croazia 1
ID - Indonesia 1
IL - Israele 1
JP - Giappone 1
MK - Macedonia 1
TR - Turchia 1
TW - Taiwan 1
Totale 3.727
Salva come PNG Salva come JPEG
Città #
Fairfield 500
Woodbridge 388
Ashburn 258
Houston 229
Seattle 218
Chandler 207
Cambridge 202
Nyköping 186
Wilmington 184
Ann Arbor 122
Beijing 75
Lawrence 64
Jacksonville 60
Roxbury 59
Nanjing 39
Des Moines 36
Inglewood 27
Dong Ket 23
Redwood City 21
Bari 19
New York 18
San Diego 18
Paris 17
Brussels 16
Princeton 14
Rome 13
Brooklyn 11
Dublin 10
Shenyang 10
Dearborn 9
London 9
Nanchang 9
Boardman 7
Changsha 7
Pune 7
Singapore 7
Vibo Valentia 7
Hebei 6
Helsinki 6
Jiaxing 6
Bologna 5
Taranto 5
Tianjin 5
Kilburn 4
Milan 4
Acton 3
Andria 3
Guangzhou 3
Haaksbergen 3
Hounslow 3
Indiana 3
Molfetta 3
Norwalk 3
Shanghai 3
Somerville 3
Washington 3
Auckland 2
Catania 2
Dallas 2
Florennes 2
Hefei 2
Hong Kong 2
Johannesburg 2
Los Angeles 2
Manchester 2
Mangalore 2
Modugno 2
Muscat 2
Napoli 2
Ningbo 2
Ome 2
Prescot 2
Rochester 2
Saint Paul 2
San Francisco 2
San Mateo 2
San Paolo 2
Sannicandro Garganico 2
Turin 2
Vienna 2
Weston 2
Xi'an 2
Zhengzhou 2
Augusta 1
Barletta 1
Budapest 1
Buffalo 1
Calgary 1
Cardano al Campo 1
Castelnuovo Rangone 1
Caxias Do Sul 1
Chicago 1
Chiswick 1
Cutrofiano 1
Dhaka 1
Edinburgh 1
Forlì 1
Fuzhou 1
Gazi 1
Hangzhou 1
Totale 3.251
Salva come PNG Salva come JPEG
Nome #
Analysis of potential response predictors to capecitabine/temozolomide in metastatic pancreatic neuroendocrine tumors 127
Exosomes in melanoma: A role in tumor progression, metastasis and impaired immune system activity 110
Everolimus restrains the paracrine pro-osteoclast activity of breast cancer cells 104
Bendamustine overcomes resistance to melphalan in myeloma cell lines by inducing cell death through mitotic catastrophe 103
Parallelism of DOG1 expression with recurrence risk in gastrointestinal stromal tumors bearing KIT or PDGFRA mutations 100
Osteotropism of neuroendocrine tumors: Role of the CXCL12/ CXCR4 pathway in promoting EMT in vitro 97
A Delphic consensus assessment: imaging and biomarkers in gastroenteropancreatic neuroendocrine tumor disease management. 96
Reviewing the Osteotropism in Neuroendocrine Tumors: The Role of Epithelial-Mesenchymal Transition 96
Lenalidomide in multiple myeloma: current experimental and clinical data 94
New insights into the molecular pathogenesis of langerhans cell histiocytosis 93
NETs: Organ-related epigenetic derangements and potential clinical applications 93
Erdheim-Chester disease: A systematic review. 91
Evaluating Risks and Benefits of Evolving Systemic Treatments of Neuroendocrine Tumors 89
Gastroenteropancreatic Neuroendocrine Tumors 87
The Tumor Microenvironment in Neuroendocrine Tumors: Biology and Therapeutic Implications 85
Immune System Evasion as Hallmark of Melanoma Progression: The Role of Dendritic Cells. 83
The Role of Cytotoxic Chemotherapy in Well-Differentiated Gastroenteropancreatic and Lung Neuroendocrine Tumors. 81
An imbalance between Beclin-1 and p62 expression promotes the proliferation of myeloma cells through autophagy regulation. 77
Management of Asymptomatic Sporadic Nonfunctioning Pancreatic Neuroendocrine Neoplasms (ASPEN) ≤2 cm: Study Protocol for a Prospective Observational Study 75
Sirtuins and Cancer: Role in the Epithelial-Mesenchymal Transition 73
Will clinical heterogeneity of neuroendocrine tumors impact their management in the future? Lessons from recent trials 73
The management of refractory carcinoid syndrome: challenges and opportunities ahead 73
The expanding role of somatostatin analogs in gastroenteropancreatic and lung neuroendocrine tumors 73
Analysis of the immune landscape of small bowel neuroendocrine tumors 72
Cell fusion in myeloma marrow microenvironment: role in tumor progression 71
Modified staging classification for pancreatic neuroendocrine tumors on the basis of the American Joint Committee on Cancer and European Neuroendocrine Tumor Society Systems 71
Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression 71
Radionuclide Therapy for Neuroendocrine Tumors 70
Phase II clinical trial of pasireotide long-acting repeatable in patients with metastatic neuroendocrine tumors 70
Circulating tumour cells and their association with bone metastases in patients with neuroendocrine tumours 68
Local treatment for focal progression in metastatic neuroendocrine tumors 67
SNPs in predicting clinical efficacy and toxicity of chemotherapy: Walking through the quicksand 67
Treatment strategies for metastatic neuroendocrine tumors of the gastrointestinal tract. 65
A phase II study of axitinib in advanced neuroendocrine tumors 64
Novel Lenalidomide-based combinations for treatment of multiple myeloma 61
Therapy for locoregional disease: pancreas 59
Local treatment for focal progression in metastatic neuroendocrine tumors 58
Analysis of Postoperative Recurrence in Stage I-III Midgut Neuroendocrine Tumors 55
Management of NETs in the Precision Medicine Era 54
Higher frequency of isolated PMS2 loss in colorectal tumors in Colombian population: preliminary results 53
Effect of vitaxin on hyperactive osteoclastogenesis in multiple myeloma: a preclinical study 51
Role of Bone Targeting Agents in the Prevention of Bone Metastases from Breast Cancer 51
Cerebellar ataxia and exercise intolerance in Erdheim-Chester disease 51
DAXX mutations as potential genomic markers of malignant evolution in small nonfunctioning pancreatic neuroendocrine tumors 46
In search of a bone metastasis (BM) gene signature in circulating tumour cells (CTCs) from stage IV breast cancer (BC) patients 42
BONE METASTASES IN NEUROENDOCRINE TUMORS: MOLECULAR PATHOGENESIS AND IMPLICATIONS IN CLINICAL PRACTICE. 41
Non-melanoma skin cancers: Biological and clinical features 37
Development of anti-somatostatin receptors CAR T cells for treatment of neuroendocrine tumors 34
Neuroendocrine tumors 34
An update on gastroenteropancreatic neuroendocrine tumors 33
Lanreotide dopo octreotide LAR nel pNET in progressione: descrizione di un caso 32
1101MO Development of CAR T-cells for future treatment of NETs 32
EPB41L5 is Associated with the Metastatic Potential of Low-grade Pancreatic Neuroendocrine Tumors 31
Novel immunotherapy strategies for treatment of neuroendocrine neoplasms 28
Emerging Treatment Options for Gastroenteropancreatic Neuroendocrine Tumors 28
Sensitivity and Specificity of the NETest: A Validation Study 26
Association of Upfront Peptide Receptor Radionuclide Therapy With Progression-Free Survival Among Patients With Enteropancreatic Neuroendocrine Tumors 25
A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms 24
Adoptive T-cell immunotherapy in digestive tract malignancies: Current challenges and future perspectives 22
Impact of the SARS-CoV2 pandemic dissemination on the management of neuroendocrine neoplasia in Italy: a report from the Italian Association for Neuroendocrine Tumors (Itanet) 21
The psychological impact of COVID-19 pandemic on patients with neuroendocrine tumors: Between resilience and vulnerability 21
Somatostatin Analogs for Pancreatic Neuroendocrine Tumors: Any Benefit When KI-67 is ≥10%? 18
Advanced small-bowel well-differentiated neuroendocrine tumours: An international survey of practice on 3rd-line treatment 18
Antiproliferative Systemic Therapies for Metastatic Small Bowel Neuroendocrine Tumours 16
Angiogenesis in NENs, with a focus on gastroenteropancreatic NENs: from biology to current and future therapeutic implications 13
An Immunohistochemical Score as Predictor of the Bone Metastasis Risk in Patients with NETs 13
An update on Merkel cell carcinoma 10
Adamantinoma-like Ewing sarcoma of the salivary glands: a case report and systematic literature review 5
The impact of COVID-19 on the management of neuroendocrine tumors (NETS): An international NET CONNECT survey of NET patients and healthcare professionals treating net patients 2
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 2
Totale 3.976
Salva come PNG Salva come JPEG
Categoria #
all - tutte 20.157
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.157
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.016 141 54 40 116 99 65 93 107 123 70 82 26
2020/2021836 34 52 33 64 184 87 68 91 33 95 42 53
2021/2022445 43 19 3 10 17 50 14 18 38 37 71 125
2022/2023629 91 108 47 31 37 91 19 88 80 2 17 18
2023/2024314 17 56 15 39 36 63 18 11 5 13 4 37
2024/202518 18 0 0 0 0 0 0 0 0 0 0 0
Totale 3.976